Trial reportScientific reports2025
Effects of family-centered empowerment program on illness acceptance and self-management of patients with type 2 diabetes: a randomized controlled trial.
Trial report in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The effect of a family-centered empowerment model with traditional Chinese medicine health education on self-management in community-dwelling older adult hypertensive patients with a chance health locus of control.Frontiers in public health · 2026Trial
- Fear of Complications Among Patients with Type 2 Diabetes: A Latent Profile Analysis.Patient preference and adherence · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In recent years, diabetes patients have been receiving more attention than ever when it comes to accepting their illness and managing it on their own. This study aimed to examine the effectiveness of a family-centered empowerment program (FCEP) on illness acceptance and self-management of patients with type 2 diabetes. We conducted a single-blind randomized controlled clinical trial with pre- and post-measurements on 60 patients with type 2 diabetes. Randomization was performed via block randomization with Sequential Numbered Opaque Sealed Envelopes. Participants were randomized into (1) FCEP (intervention group) or (2) usual care (control group). Data collection was conducted by using a demographic questionnaire, the Diabetes Self-Management Questionnaire (DSMQ), and the Diabetes Acceptance Scale (DAS). The assessment of outcome measures occurred at baseline and immediately, and six weeks after the intervention. The results showed that at the baseline, there was no significant difference between intervention and control groups in terms of illness acceptance (Intervention (I): 32.17 ± 10.59 vs. Control (C): 34.53 ± 10.6; p = 0.396). However, immediately after the intervention (I: 41.79 ± 8.94 vs. C: 34.86 ± 10.63; P = 0.008) and 6 weeks after the intervention (I: 47.1 ± 5.72 vs. C: 34.66 ± 10.54; P < 0.001), there was a significant difference between intervention and control groups in terms of illness acceptance. In addition, the results showed that, at the baseline, there was no significant difference between intervention and control groups in terms of self-management (I: 21.72 ± 5.36 vs. C: 22.96 ± 3.65; p = 0.305). However, immediately after the intervention (I: 30.93 ± 2.2 vs. C: 23.63 ± 2.95; P < 0.001) and 6 weeks after the intervention (I: 36.37 ± 2.39 vs. C: 23.26 ± 3.11; P < 0.001), there was a significant difference between intervention and control groups in terms of self-management. The findings of this study demonstrated that the FCEP intervention effectively improves illness acceptance and self-management. Healthcare practitioners, particularly nurses, can enhance the acceptance of illness and self-management in patients with type 2 diabetes through the implementation of the FCEP.Ethical considerations: This study was approved by the Research Committee of Shahid Beheshti University of Medical Sciences (No: IR.SBMU.PHARMACY.REC.1403.002).Protocol Registration: The study protocol was registered in the Iranian Registry of Clinical Trials (No: IRCT20240624062246N1, 16/07/2024).
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.